Research programme: casein kinase 2 inhibitors - Kyoto University/Toray/Tokyo Womens Medical University

Drug Profile

Research programme: casein kinase 2 inhibitors - Kyoto University/Toray/Tokyo Womens Medical University

Alternative Names: Casein kinase 2 inhibitors research programme - Kyoto University/Toray/Tokyo Womens Medical University

Latest Information Update: 28 Aug 2007

Price : $50

At a glance

  • Originator Kyoto University; Tokyo Medical University; Toray
  • Class
  • Mechanism of Action Phosphotransferase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Nephritis

Most Recent Events

  • 03 Jun 2005 Preclinical trials in Nephritis in Japan (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top